KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Precigen (PGEN) Invested Capital (2016 - 2025)

Historic Invested Capital for Precigen (PGEN) over the last 14 years, with Q3 2025 value amounting to $134.8 million.

  • Precigen's Invested Capital rose 14335.09% to $134.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $134.8 million, marking a year-over-year increase of 14335.09%. This contributed to the annual value of $38.5 million for FY2024, which is 6749.9% down from last year.
  • Per Precigen's latest filing, its Invested Capital stood at $134.8 million for Q3 2025, which was up 14335.09% from -$36.8 million recorded in Q2 2025.
  • In the past 5 years, Precigen's Invested Capital registered a high of $349.3 million during Q1 2021, and its lowest value of -$36.8 million during Q2 2025.
  • In the last 5 years, Precigen's Invested Capital had a median value of $166.2 million in 2023 and averaged $166.1 million.
  • Data for Precigen's Invested Capital shows a peak YoY increase of 14335.09% (in 2025) and a maximum YoY decrease of 18519.57% (in 2025) over the last 5 years.
  • Precigen's Invested Capital (Quarter) stood at $287.3 million in 2021, then plummeted by 41.01% to $169.5 million in 2022, then tumbled by 30.08% to $118.5 million in 2023, then crashed by 67.5% to $38.5 million in 2024, then surged by 249.9% to $134.8 million in 2025.
  • Its last three reported values are $134.8 million in Q3 2025, -$36.8 million for Q2 2025, and -$14.1 million during Q1 2025.